Roche to Acquire Digital Pathology Firm PathAI for Cancer Diagnosis and Treatment
Roche plans to acquire digital pathology firm PathAI in a deal potentially worth over $1 billion, with the goal of improving cancer diagnosis and tailored treatment.
Digital Health / MedTech / BioTech